MolNFT v1 · #187110 · protein
PRMT5/MEP50 crystal structure with mta and a phthalazinone inhibitor bound (compound 9)
7S1Q: “PRMT5/MEP50 crystal structure with mta and a phthalazinone inhibitor bound (compound 9)”. X-ray diffraction, 2 ligands (MTA, 84W). MolNFT v1 #187110 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 7S1Q
- Type
- protein
- Length
- 922 residues
- Chains
- 2
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- UniProt
- O14744, Q9BQA1
- Ligands
- MTA, 84W
Structure
x-ray diffraction · 2 distinct chains.
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | — | protein | 625 | — | O14744 |
| B | — | protein | 297 | — | Q9BQA1 |
Ligands and binding sites
- MTA · 5'-deoxy-5'-methylthioadenosine · ligand · chains A
- 84W · [7-(1-methyl-1H-pyrazol-4-yl)-4-oxo-3,4-dihydrophthalazin-1-yl]methanaminium · ligand · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Compared structures
- 7S1Q · PRMT5/MEP50 crystal structure with MTA and a phthalazi inhibitor bound (Compound 9) · the same entry in another collection · chain A against A, TM-score 1.00
- Q9BQA1 · AlphaFold monomer V2.0 prediction for methylosome protein 50 (Q9BQA1) · a predicted model of the same protein · chain B against A, TM-score 1.00
- O14744 · AlphaFold monomer V2.0 prediction for protein arginine N-methyltransferase 5 (O14744) · a predicted model of the same protein · chain A against A, TM-score 0.97
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt O14744
- Every structure of UniProt Q9BQA1
- Elsewhere: RCSB PDB 7S1Q · PDBe 7S1Q · UniProt O14744 · UniProt Q9BQA1
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.